A Gaucher Disease Gene Therapy Trial With FLT201
NCT07223944
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
45
Enrollment
INDUSTRY
Sponsor class
Conditions
Gaucher Disease Type 1
Interventions
GENETIC:
FLT201
Sponsor
Spur Therapeutics